Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ASPIRA PATHLAB & DIAGNOSTICS LTD.

NSE : NABSE : 540788ISIN CODE : INE500C01017Industry : Hospital & Healthcare ServicesHouse : Private

BSE62.902.05 (+3.37 %)

PREV CLOSE ( ) 60.85

OPEN PRICE ( ) 57.81

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1446

TODAY'S LOW / HIGH ( )57.81 63.89

52 WK LOW / HIGH ( ) 30106.78

NSE

This Company is not listed in NSE

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Net Sales

52.48

57.77

54.07

61.78

Total Expenditure

44.27

47.24

46.4

48.21

PBIDT (Excl OI)

8.20

10.53

7.67

13.57

Other Income

1.08

1.3

0.89

0.76

Operating Profit

9.29

11.83

8.56

14.32

Interest

0.94

0.93

0.94

0.79

Exceptional Items

PBDT

8.35

10.9

7.62

13.53

Depreciation

3.65

3.67

3.86

3.64

Profit Before Tax

4.70

7.23

3.76

9.89

Tax

Provisions and contingencies

Profit After Tax

4.70

7.23

3.76

9.89

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

4.70

7.23

3.76

9.89

Minority Interest

Shares of Associates

-0.48

-0.43

-0.7

Other related items

Misc. Expenses Written off

Consolidated Net Profit

4.22

6.81

3.06

9.9

Equity Capital

102.93

Face Value (IN RS)

Reserves

Calculated EPS

0.40

0.66

0.29

0.96

Calculated EPS (Annualised)

1.63

2.64

1.18

3.84

No of Public Share Holdings

8400037

8384036

% of Public Share Holdings

81.61

81.45

PBIDTM% (Excl OI)

15.64

18.22

14.18

21.96

PBIDTM%

17.70

20.47

15.83

23.17

PBDTM%

15.91

18.86

14.09

21.90

PBTM%

8.95

12.51

6.95

16.00

PATM%

8.95

12.51

6.95

16.00

Notes

Risk Disclosures on Derivatives

Quarterly Results

ASPIRA PATHLAB & DIAGNOSTICS LTD.